BD

Bassil Dahiyat

North America, California, United States, Monrovia

Description

Bassil Dahiyat is the CEO of Xencor. He attended Caltech and Johns Hopkins University.

Investor Profile

Bassil Dahiyat has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Biopharma, Biotechnology.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biopharma
  • Biotechnology
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bassil Dahiyat frequently co-invest with?

N
North America, California, United States, Santa Clara
Co-Investments: 1

Which angels does Bassil Dahiyat often collaborate with?

JM
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Bassil Dahiyat?

Terray Therapeutics

Pasadena, California, United States

Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.

Artificial Intelligence (AI)BiopharmaBiotechnologyLife ScienceMedical
Series UnknownNov 9, 2023